The gut-brain axis: Psychobiotic opportunity in 25 countries
€2,200
What this report tells you
- How products are falling into three broad categories: Common, Committed and Clinical
- How ingredients are being blended
- What kinds of claims are in play
- Where the science stands and where it is going
- How keyword general searches influence marketing
- Which strains are delivering benefits
- Why the pharma sector is so interested
- What major brands and suppliers think
About the report
Published March 2022. The Gut-Brain Axis (GBX) is a research concept that has moved into the mainstream consciousness via mostly probiotic supplement makers that offer to alter the microbiota via probiotic supplementation which benefits brain health in some way. The scientific base is small but developing clinically, growing fast and boosted by the broader surge in microbiome study across a range of nutritional interventions that include probiotics.
Lumina reveals the evolution of ‘psychobiotics’ in 25 e-commerce markets from the brands winning the most loyal consumer engagement (and how), to the most innovative markets to business-ready scans of the e-tail environment, science, suppliers, regulations that shape the markets.
Report example
- Global Market Overview
- Mental Health In Crisis
- Inside Psychobiotics – Stress
- Inside Psychobiotics – Mood
- Inside Psychobiotics – Gbx
- Inside Psychobiotics – Sleep
- Inside Psychobiotics – Cognitive Health
- Inside Psychobiotics – Clinical
- Science & Regulations
- Supply Sides
- Appendix: Regional Infographics
- About & Methodology
About the author
Customer Testimonials
Download an extract of the report
See if this report is right for you by previewing an extract!